Triveni Bio
Develops novel antibody treatments for immunological and inflammatory disorders
$65MSeries C
Role not disclosedActivity from announced rounds
Develops novel antibody treatments for immunological and inflammatory disorders
Develops inhaled therapies for severe respiratory diseases